| scholarly article | Q13442814 |
| P2093 | author name string | Haim Bitterman | |
| Nitza Lahat | |||
| Ron Auslender | |||
| Sarah Shapiro | |||
| Olga Khodalev | |||
| P2860 | cites work | Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties | Q28268723 |
| Structure and function of matrix metalloproteinases and TIMPs | Q30014818 | ||
| Human endothelial gelatinases and angiogenesis | Q34317873 | ||
| TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains | Q34545340 | ||
| New insights into the function and regulation of endothelial cell apoptosis | Q35712021 | ||
| Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). | Q35770288 | ||
| Metalloproteinases and their inhibitors in tumor angiogenesis | Q36053766 | ||
| Mechanisms of endothelial dysfunction, injury, and death | Q37255202 | ||
| p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). | Q40533259 | ||
| Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis | Q40537092 | ||
| Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase | Q40716284 | ||
| Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. | Q41832788 | ||
| Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells | Q43618959 | ||
| MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen | Q43845368 | ||
| Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis. | Q44012013 | ||
| Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2. | Q44116626 | ||
| p38 MAPK inhibition is critically involved in VEGFR-2-mediated endothelial cell survival | Q44480233 | ||
| Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. | Q45938289 | ||
| Activation of p38 has opposing effects on the proliferation and migration of endothelial cells | Q46404136 | ||
| Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells. | Q51033758 | ||
| MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. | Q52560874 | ||
| Hypoxia-induced apoptosis and tube breakdown are regulated by p38 MAPK but not by caspase cascade in an in vitro capillary model composed of human endothelial cells. | Q53564610 | ||
| Hypoxia induces apoptosis of HUVECs in an in vitro capillary model by activating proapoptotic signal p38 through suppression of ERK1/2. | Q53570889 | ||
| Nitric oxide and p38 MAP kinase mediate shear stress-dependent inhibition of MMP-2 production in microvascular endothelial cells. | Q53629670 | ||
| P433 | issue | 4 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | C942-51 | |
| P577 | publication date | 2010-01-13 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | Different activation forms of MMP-2 oppositely affect the fate of endothelial cells | |
| P478 | volume | 298 |
| Q34334378 | Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression |
| Q30408109 | Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway |
| Q46053599 | Differential regulation of collagen, lysyl oxidase and MMP-2 in human periodontal ligament cells by low- and high-level mechanical stretching |
| Q51242582 | Feline Injection-Site Sarcoma. |
| Q41435242 | Hypoxia induces calpain activity and degrades SMAD2 to attenuate TGFβ signaling in macrophages |
| Q48061925 | Inhibition of Gelatinases (MMP-2 and MMP-9) by Withania somnifera Phytochemicals Confers Neuroprotection in Stroke: An In Silico Analysis. |
| Q37784801 | Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. |
| Q35175533 | Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q38871902 | Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability |
| Q35007715 | Physiology and pathophysiology of matrix metalloproteases. |
| Q39621316 | Reduced TIMP-2 in hypoxia enhances angiogenesis |
| Q37414161 | Superficial Burn Wound Healing with Intermittent Negative Pressure Wound Therapy Under Limited Access and Conventional Dressings |
| Q27303955 | TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression |
Search more.